These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 23835189)
1. Effect of therapeutic arsenic exposure on pulmonary function. Ho JC; Au WY; Han L; Kwong YL; Ip MS Respir Med; 2013 Sep; 107(9):1423-30. PubMed ID: 23835189 [TBL] [Abstract][Full Text] [Related]
2. Age-associated changes in pulmonary function: a comparison of pulmonary function parameters in healthy young adults and the elderly living in Shanghai. Ren WY; Li L; Zhao RY; Zhu L Chin Med J (Engl); 2012 Sep; 125(17):3064-8. PubMed ID: 22932182 [TBL] [Abstract][Full Text] [Related]
4. Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity. Vandevoorde J; Verbanck S; Schuermans D; Broekaert L; Devroey D; Kartounian J; Vincken W Eur Respir J; 2008 Feb; 31(2):391-5. PubMed ID: 17928313 [TBL] [Abstract][Full Text] [Related]
5. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Jiang H; Chen SJ; Huang XJ J Clin Oncol; 2013 Nov; 31(33):4215-21. PubMed ID: 24127444 [TBL] [Abstract][Full Text] [Related]
6. Kurtosis and skewness of density histograms on inspiratory and expiratory CT scans in smokers. Yamashiro T; Matsuoka S; Estépar RS; Bartholmai BJ; Diaz A; Ross JC; Murayama S; Silverman EK; Hatabu H; Washko GR COPD; 2011 Feb; 8(1):13-20. PubMed ID: 21299474 [TBL] [Abstract][Full Text] [Related]
7. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin. Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231 [TBL] [Abstract][Full Text] [Related]
8. Lung function outcome at school age in very low birth weight children. Cazzato S; Ridolfi L; Bernardi F; Faldella G; Bertelli L Pediatr Pulmonol; 2013 Aug; 48(8):830-7. PubMed ID: 23129340 [TBL] [Abstract][Full Text] [Related]
9. [Changes in pulmonary function in SARS patients during the three-year convalescent period]. Liu YX; Ye YP; Zhang P; Chen J; Ye H; He YH; Li N Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):536-8. PubMed ID: 17767822 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo. Zhao XS; Song PL; Sun B; Jiang HC; Liu TF Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495 [TBL] [Abstract][Full Text] [Related]
11. Effect of arsenic trioxide on QT interval in patients with advanced malignancies. Barbey JT; Pezzullo JC; Soignet SL J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391 [TBL] [Abstract][Full Text] [Related]
12. Entry of elemental arsenic into the central nervous system in patients with acute promyelocytic leukemia during arsenic trioxide treatment. Au WY; Tam S; Kwong YL Leuk Res; 2008 Feb; 32(2):357-8. PubMed ID: 17662385 [No Abstract] [Full Text] [Related]
13. Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia. Lengfelder E; Hofmann WK; Nowak D Leukemia; 2012 Mar; 26(3):433-42. PubMed ID: 21904379 [TBL] [Abstract][Full Text] [Related]
14. Non-lethal bone marrow necrosis under first-line arsenic trioxide therapy in acute promyelocytic leukaemia. Ianotto JC; Tempescul A; Eveillard JR; Charles F; Berthou C Acta Haematol; 2010; 123(3):146-7. PubMed ID: 20134156 [No Abstract] [Full Text] [Related]
15. Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia. Zhang Y; Zhang Z; Li J; Li L; Han X; Han L; Hu L; Wang S; Zhao Y; Li X; Zhang Y; Fan S; Lv C; Li Y; Su Y; Zhao H; Zhang X; Zhou J Cancer; 2013 Jan; 119(1):115-25. PubMed ID: 22930197 [TBL] [Abstract][Full Text] [Related]
16. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. Lo-Coco F; Avvisati G; Vignetti M; Thiede C; Orlando SM; Iacobelli S; Ferrara F; Fazi P; Cicconi L; Di Bona E; Specchia G; Sica S; Divona M; Levis A; Fiedler W; Cerqui E; Breccia M; Fioritoni G; Salih HR; Cazzola M; Melillo L; Carella AM; Brandts CH; Morra E; von Lilienfeld-Toal M; Hertenstein B; Wattad M; Lübbert M; Hänel M; Schmitz N; Link H; Kropp MG; Rambaldi A; La Nasa G; Luppi M; Ciceri F; Finizio O; Venditti A; Fabbiano F; Döhner K; Sauer M; Ganser A; Amadori S; Mandelli F; Döhner H; Ehninger G; Schlenk RF; Platzbecker U; ; ; N Engl J Med; 2013 Jul; 369(2):111-21. PubMed ID: 23841729 [TBL] [Abstract][Full Text] [Related]
17. Lung function in children with diabetes mellitus. Cazzato S; Bernardi F; Salardi S; Tassinari D; Corsini I; Ragni L; Cicognani A; Cacciari E Pediatr Pulmonol; 2004 Jan; 37(1):17-23. PubMed ID: 14679484 [TBL] [Abstract][Full Text] [Related]
18. Herpes zoster during treatment with arsenic trioxide. Tanvetyanon T; Nand S Ann Hematol; 2004 Mar; 83(3):198-200. PubMed ID: 15064871 [TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen. Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309 [TBL] [Abstract][Full Text] [Related]
20. Impairment of heart rate variability control during arsenic trioxide treatment for acute promyelocytic leukemia. Takeshita A; Uehara A; Shinjo K; Naito K; Sahara N; Yamazaki K; Katoh H; Kamikawa T; Ohnishi K; Maekawa M; Hayashi H; Ohno R Leukemia; 2004 Mar; 18(3):647-8. PubMed ID: 14671633 [No Abstract] [Full Text] [Related] [Next] [New Search]